Prothena Corp (PRTA)
9.06 x 1 N/A x N/A
Pre-market by (Cboe BZX)
9.20 -0.49 (-5.06%) 04/30/25 [NASDAQ]
9.06 x 1 N/A x N/A
Pre-market 9.20 unch (unch) 16:00 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | PRTA | GHRS | CGEM | ||
| Company | Prothena Corp | Gh Research Plc | Cullinan Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.45 | 8.82 | 7.79 | ||
| High | 9.57 | 9.63 | 8.40 | ||
| Low | 9.17 | 8.75 | 7.70 | ||
| Last | 9.20 | 9.54 | 8.28 | ||
| Change | -0.49 | +0.54 | +0.38 | ||
| % Change | -5.06% | +6.00% | +4.81% | ||
| Volume | 989,600 | 228,700 | 358,600 | ||
| 20-Day Average Volume | 637,345 | 200,030 | 500,225 | ||
| Previous Close | 9.69 | 9.00 | 7.90 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.01 | 9.32 | 7.82 | ||
| 20-Day Raw Stochastic | 6.27% | 51.83% | 73.71% | ||
| 20-Day Relative Strength | 32.68% | 46.10% | 50.12% | ||
| Weighted Alpha | -63.92 | -27.94 | -68.60 | ||
| Today's Opinion | 100% Sell | 8% Sell | 64% Sell | ||
| Previous Opinion | 100% Sell | 40% Sell | 80% Sell | ||
| Last Month's Opinion | 100% Sell | 48% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.07% since 04/23/25 | +0.42% since 04/23/25 | -1.19% since 04/23/25 | ||
| Low | 9.17 on 04/30/25 | 8.75 on 04/30/25 | 7.61 on 04/28/25 | ||
| High | 9.98 on 04/24/25 | 10.00 on 04/28/25 | 8.41 on 04/24/25 | ||
| 1-Month | |||||
| %Chg | -29.98% since 03/28/25 | -13.74% since 03/28/25 | +3.24% since 03/28/25 | ||
| Low | 9.00 on 04/21/25 | 7.98 on 04/09/25 | 6.85 on 04/07/25 | ||
| High | 12.70 on 03/31/25 | 11.28 on 03/31/25 | 8.79 on 04/23/25 | ||
| 3-Month | |||||
| %Chg | -37.41% since 01/30/25 | -1.55% since 01/30/25 | -24.59% since 01/30/25 | ||
| Low | 9.00 on 04/21/25 | 7.98 on 04/09/25 | 6.85 on 04/07/25 | ||
| High | 16.67 on 02/21/25 | 20.50 on 02/03/25 | 11.28 on 01/31/25 | ||
| 6-Month | |||||
| %Chg | -49.12% since 10/30/24 | +14.53% since 10/30/24 | -48.95% since 10/30/24 | ||
| Low | 9.00 on 04/21/25 | 6.72 on 12/20/24 | 6.85 on 04/07/25 | ||
| High | 18.77 on 11/06/24 | 20.50 on 02/03/25 | 17.50 on 11/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 495,208 | 496,347 | 488,644 | ||
| Shares Outstanding, K | 53,827 | 52,028 | 59,015 | ||
| Annual Sales | 135,160,000 | 0 | 0 | ||
| Annual Net Income | -122,310,000 | -38,960,000 | -167,380,000 | ||
| Last Quarter Sales | 2,120,000 | 0 | 0 | ||
| Last Quarter Net Income | -57,960,000 | -8,800,000 | -47,650,000 | ||
| 60-Month Beta | 0.07 | 0.84 | -0.05 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.08 on 02/20/25 | -0.17 on 02/27/25 | -0.73 on 02/27/25 | ||
| Latest Earnings Date | 05/14/25 | 05/02/25 | 05/21/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||